Literature DB >> 484565

Effect of an antacid on gastrointestinal absorption of theophylline.

L A Arnold, G H Spurbeck, W H Shelver, W M Henderson.   

Abstract

The effect of a magnesium-aluminum hydroxide antacid (Maalox) on the oral absorption of aminophylline tablets was studied. Twelve healthy adults were administered 200 mg of aminophylline alone or with 30 ml of antacid in a complete crossover study. Blood samples were drawn at 0.33, 0.67, 1, 2, 4, 8, 12, and 24 hours following theophylline (as aminophylline) administration. Theophylline plasma levels were measured by high-performance liquid chromatography. The plasma theophylline concentrations of the group receiving theophylline only were significantly greater than those of the group receiving theophylline plus antacid at the 0.67- and 1-hour sample times only (p less than 0.05). The extent of theophylline absorption and the eliminated rate constant were not significantly affected by the antacid. Antacid significantly decreased theophylline's absorption rate constant (p less than 0.05), indicating a slower absorption of theophylline with antacid. Concurrent administration of the antacid Maalox should not significantly change theophylline's clinical effect.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 484565

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  11 in total

Review 1.  Pharmacokinetic interactions between theophylline and other medication (Part II).

Authors:  R A Upton
Journal:  Clin Pharmacokinet       Date:  1991-02       Impact factor: 6.447

Review 2.  Clinically significant drug interactions with antacids: an update.

Authors:  Ryuichi Ogawa; Hirotoshi Echizen
Journal:  Drugs       Date:  2011-10-01       Impact factor: 9.546

Review 3.  Clinical pharmacokinetics of capecitabine.

Authors:  B Reigner; K Blesch; E Weidekamm
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

Review 4.  A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products.

Authors:  L Hendeles; R P Iafrate; M Weinberger
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

Review 5.  Theophylline poisoning. Pharmacological considerations and clinical management.

Authors:  P Gaudreault; J Guay
Journal:  Med Toxicol       Date:  1986 May-Jun

6.  The influence of antacid on the absorption of two different sustained-release formulations of theophylline.

Authors:  K I Myhre; R A Walstad
Journal:  Br J Clin Pharmacol       Date:  1983-06       Impact factor: 4.335

Review 7.  Pharmacokinetic drug interactions with theophylline.

Authors:  J H Jonkman; R A Upton
Journal:  Clin Pharmacokinet       Date:  1984 Jul-Aug       Impact factor: 6.447

8.  Lack of effect of magnesium-aluminium hydroxide on the absorption of theophylline given as a pH-dependent sustained release preparation.

Authors:  J F Muir; G Peiffer; M O Richard; D Benhamou; M Andrejak; L Hary; N Moore
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

9.  Individualized aminophylline therapy in patients with obstructive airway disease: oral dosage prediction from an intravenous test dose.

Authors:  Y Horai; T Ishizaki; T Sasaki; M Watanabe; J Kabe
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

10.  Lack of influence of an intensive antacid regimen on theophylline bioavailability.

Authors:  R C Reed; H J Schwartz
Journal:  J Pharmacokinet Biopharm       Date:  1984-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.